Branded Legacy, Inc. Acquires Sycamore BioPharma, Inc.

Branded Legacy, Inc Acquires All In Extracts LLC

January 9, 2024

Biotechnology

Branded Legacy, Inc. (OTC.PK: BLEG), a Melbourne, Florida–based pharmaceutical biotechnology company, has completed the acquisition of All In Extracts LLC, a Tampa, Florida–based medicinal ethnobotany and botanical extracts manufacturer. The deal adds proprietary delivery systems, lab and cultivation capacity (including 800 sq ft of lab space and 16 acres of grow space) to Branded Legacy’s subsidiaries and supports product and capability expansion into supplements and related health-and-wellness markets.

Branded Legacy, Inc. Acquires MariJ Pharmaceuticals, Inc.

December 4, 2023

Biotechnology

Branded Legacy, Inc. (OTC: BLEG) completed the acquisition of MariJ Pharmaceuticals, Inc., a Clearwater, Florida-based certified-organic CBD extraction and production company, on December 4, 2023. The deal transfers MariJ's mobile CO2 extraction units, licensed vehicles, production lab, IP (including a patent), organic certifications, customer and operational databases, and licenses to Branded Legacy in exchange for preferred series stock and cash.

Branded Legacy, Inc. Acquires Spikes CBDx

February 4, 2021

Consumer Products

Branded Legacy, Inc. (OTCQB: BLEG), a hemp and cannabinoid-infused beverages and CBD products holding company, has acquired Spikes CBDx, LLC, a CBD product line founded by Brandon Spikes. The deal gives Spikes CBDx access to Branded Legacy's distribution and fulfillment capabilities and brings the founder into Branded Legacy as Chairman of the Board to support growth in sports recovery and topical/tincture product channels.

Nutra-Med Acquires Legacy Pharma Solutions

October 22, 2024

Manufacturing

Nutra-Med, a portfolio company of GenNx360 Capital Partners, has acquired Legacy Pharma Solutions, a St. Louis-based provider of oral solid dose contract packaging. The acquisition adds high-speed bottling and blistering capabilities to Nutra-Med, expanding its contract packaging capacity for pharmaceutical, OTC and medical device customers.

Sycamore Partners Acquires Walgreens Boots Alliance

August 28, 2025

Healthcare Services

Sycamore Partners, in partnership with Stefano Pessina and his family, completed the acquisition of Walgreens Boots Alliance, taking the company private and separating its businesses to operate as standalone companies. Following the closing, Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD will operate independently to pursue focused growth under private ownership.

Bayer AG Acquires Asklepios BioPharmaceutical (AskBio)

October 26, 2020

Biotechnology

Bayer AG agreed to acquire U.S.-headquartered Asklepios BioPharmaceutical (AskBio), adding AskBio's AAV-based gene therapy platform, IP and CDMO manufacturing capabilities to Bayer’s emerging cell and gene therapy unit. Bayer will pay $2.0 billion upfront plus up to $2.0 billion in potential milestone payments; existing minority shareholders TPG Capital and Vida Ventures supported the transaction.